What is known so far is that treatment with specific inhibitors such as vorinostat, pembrolizumab, IDO inhibitor, HO-1 inhibitor improves the cytotoxicity of NK cells in cervical cancer [76,79,81,98]. This evidence concerns the gene HMOX1 and cervical cancer.